Table 2.
Rate of multi (M), extensively (X), and pan (P) drug-resistant (DR) Gram-negative microorganisms.
| Microorganisms | MDR | XDR | PDR | CP-R | ESBL Producer |
|---|---|---|---|---|---|
| Pseudomonas spp. | 17.4–26.6% | ||||
| Pseudomonas aeruginosa | 15.7–39.6% | 8.9–23%% | 2–5.9% | 4.5–35% | 17–90% |
| Klebiella spp. | Case-reports-3.9/4.3% | 6.7–8.5% | 2.5–100.0% 18% |
||
| Klebsiella pneumoniae | 2–44.6% | 7–26.6% | <1–50% | ||
| Klebsiella oxytoca | 2% | 3% | <1% | ||
| Escherichia coli | 2–50% | 7.7–11.5% | 5–6.2% | 0.1–12.1% | 0 |
| Acinetobacter spp. | 31–70/90% | 12.29% | 56.6–77% | ||
| Acinetobacter calcoaceticus baumanii complex | 15–40% | 14.2–20% | 90–99% | ||
| Enterobacter spp. | 2–28.7% | 16% | 2.4–6.7% | 0.9–1.7% | |
| Enterobacter cloacae | 6–22% | ||||
| Peoteus mirabilis | 3.8% | 15.7% | 0.7–1.7 | 4.6% | |
| Stenotrophomonas maltophilia | 17–30.5% | 39.4% | / | / | 0 |
| Serratia spp. | 30% | 4.7–6.2% | 1.5% | 0.3–1.5% | 0 |
| Citrobacter spp. | 34.5% | 1% | <1% | 0.5–1% | 0 |